Clinical trial
Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating…
NCT00045461 · Ludwig-Maximilians - University of Munich, Other · Unknown status
Key facts
| NCT number | NCT00045461 |
|---|---|
| Title | Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer |
| Official title | A Randomized Phase II/III Trial Comparing Carboplatin-Ifosfamide (IC)-Chemotherapy Vs. IC-Chemotherapy Combined With Extreme Whole Body Hyperthermia In Patients With Recurrence Of Epithelial Ovarian Carcinoma: DOLPHIN-1-STUDY |
| Lead sponsor | Ludwig-Maximilians - University of Munich, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Drug, Procedure |
| Interventions | carboplatin, ifosfamide, hyperthermia treatment |
| Enrollment | 241 |
| Start date | Jun 1, 2000 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 7, 2013 |
| Countries | Germany, Hungary, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: